SCHEMBL8080263

SCHEMBL8080263

Nn1cncc2nnc(Br)c1-2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14742185 0.76 KDM4E (0.31)
SCHEMBL2008684 0.60 LTA4H (0.37)
SCHEMBL11199123 0.50
SCHEMBL27943609 0.42
SCHEMBL1477717 0.41
SCHEMBL1444312 0.41
SCHEMBL4974 0.39
SCHEMBL610831 0.36
SCHEMBL11607518 0.35
SCHEMBL31634339 0.35 LMNA (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6143749-A Heterocyclic substituted cyclopentane compounds ABBOTT LABORATORIES (US) 2000-11-07 US disclosed
EP-0873340-A1 HETEROCYCLIC SUBSTITUTED CYCLOPENTANE COMPOUNDS Abbott Laboratories (US) 1998-10-28 EP disclosed
US-5665721-A ADENOSINE KINASE INHIBITORS ABBOTT LABORATORIES (US) 1997-09-09 US disclosed
WO-1996040686-A1 HETEROCYCLIC SUBSTITUTED CYCLOPENTANE COMPOUNDS ABBOTT LABORATORIES (US) 1996-12-19 WO disclosed